Clinical Trials Browser

Phase EARLY_PHASE1 × daratumumab × Genitourinary × Clear all

NCT03473730 2025-01-30

Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer

Phase EARLY_PHASE1 Completed

Carcinoma, Renal Cell, Urologic Neoplasms